NIKE, Inc. (NKE)
After hours:
| Previous close | 109.62 |
| Open | 109.65 |
| Bid | 107.53 x 900 |
| Ask | 108.20 x 1100 |
| Day's range | 106.75 - 110.53 |
| 52-week range | 82.22 - 173.35 |
| Volume | |
| Avg. volume | 8,935,826 |
| Market cap | 172.84B |
| Beta (5Y monthly) | 1.14 |
| PE ratio (TTM) | 30.66 |
| EPS (TTM) | 3.52 |
| Earnings date | 20 Dec 2022 |
| Forward dividend & yield | 1.36 (1.24%) |
| Ex-dividend date | 02 Dec 2022 |
| 1y target est | 110.03 |
- Motley Fool
Bear Market Bargain Hunting: 3 Top Stocks to Buy Before 2023
Three good examples are Teladoc Health (NYSE: TDOC), Nike (NYSE: NKE), and Crispr Therapeutics (NASDAQ: CRSP). Two billion-dollar noncash goodwill impairment charges hurt Teladoc's earnings this year -- and investor sentiment. More than half of Fortune 500 companies are clients.
- Yahoo Finance Video
Nike cuts ties with Kyrie Irving over antisemitism, cancels shoe line launch
Nike has severed its ties with NBA star Kyrie Irving following his repeated antisemitic comments and has canceled the launch of his signature shoe, the Kyrie 8.
- Financial Times
Nike terminates Kyrie Irving contract after anti-Semitism controversy
Nike has severed its contract with US basketball star Kyrie Irving after the Brooklyn Nets guard promoted an anti-Semitic film on social media, the latest fallout amid a rise in high-profile hate speech. Nike, the world’s largest sportswear maker by revenues, had suspended its relationship with Irving a month ago. A spokesperson on Monday said Irving “is no longer a Nike athlete”.
